HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17.

Abstract
All ligands of the epidermal growth factor receptor (EGFR), which has important roles in development and disease, are made as transmembrane precursors. Proteolytic processing by ADAMs (a disintegrin and metalloprotease) regulates the bioavailability of several EGFR-ligands, yet little is known about the enzyme responsible for processing the recently identified EGFR ligand, epigen. Here we show that ectodomain shedding of epigen requires ADAM17, which can be stimulated by phorbol esters, phosphatase inhibitors and calcium influx. These results suggest that ADAM17 might be a good target to block the release of bioactive epigen, a highly mitogenic ligand of the EGFR which has been implicated in wound healing and cancer.
AuthorsUmut Sahin, Carl P Blobel
JournalFEBS letters (FEBS Lett) Vol. 581 Issue 1 Pg. 41-4 (Jan 09 2007) ISSN: 0014-5793 [Print] England
PMID17169360 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • EPGN protein, human
  • Epgn protein, mouse
  • Epigen
  • Growth Substances
  • Ligands
  • Membrane Proteins
  • Protease Inhibitors
  • Protein Precursors
  • Epidermal Growth Factor
  • ErbB Receptors
  • ADAM Proteins
  • ADAM17 Protein
  • ADAM17 protein, human
  • Adam17 protein, mouse
Topics
  • ADAM Proteins (antagonists & inhibitors, genetics, metabolism)
  • ADAM17 Protein
  • Animals
  • Cells, Cultured
  • Epidermal Growth Factor (genetics, metabolism)
  • Epigen
  • ErbB Receptors (agonists, genetics, metabolism)
  • Fibroblasts (cytology, enzymology)
  • Growth Substances (genetics, metabolism)
  • Humans
  • Ligands
  • Membrane Proteins (genetics, metabolism)
  • Mice
  • Neoplasms (genetics, metabolism)
  • Protease Inhibitors (pharmacology)
  • Protein Precursors (genetics, metabolism)
  • Protein Processing, Post-Translational (drug effects, physiology)
  • Protein Structure, Tertiary (genetics)
  • Wound Healing (drug effects, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: